Advanced search
Publication Cover
Future Medicinal Chemistry Volume 7, 2015 - Issue 16
Submit an article Journal homepage
140
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Paving the Way to Targeting HECT Ubiquitin Ligases

Giovanna Zinzalla1 Microbiology, Tumor and Cell Biology (MTC) Department, and Science for Life Laboratory (SciLifeLab), Karolinska Institutet, Tomtebodavägen 23, Stockholm 171 65, SwedenCorrespondence[email protected]
View further author information
Pages 2107-2111 | Published online: 29 Oct 2015

References

  • Bedford L , LoweJ, DickLR, MayerRJ, BrownellJE. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat. Rev. Drug Discov.10 (1), 29–46 (2011).
  • Landré V , RotblatB, MelinoS, BernassolaF, MelinoG. Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities. Oncotarget5 (18), 7988–8013 (2014).
  • Goldenberg SJ , MarblestoneJG, MatternMR, NicholsonB. Strategies for the identification of ubiquitin ligase inhibitors. Biochem. Soc. Trans.38 (Pt 1), 132–136 (2010).
  • Skaar JR , PaganJK, PaganoM. SCF ubiquitin ligase-targeted therapies. Nat. Rev. Drug Discov.13 (12), 889–903 (2014).
  • Berndsen CE , WolbergerC. New insights into ubiquitin E3 ligase mechanism. Nat. Struct. Mol. Biol.21 (4), 301–307 (2014).
  • Bernassola F , KarinM, CiechanoverA, MelinoG. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell14 (1), 10–21 (2008).
  • Kamadurai HB , QiuY, DengAet al. Mechanism of ubiquitin ligation and lysine prioritization by a HECT E3. eLife2, e00828 (2013).
  • Rossi M , RotblatB, AnsellKet al. High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. Cell Death Dis.5, e1203 (2014).
  • Peter S , BultinckJ, MyantKet al. Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase. EMBO Mol. Med.6 (12), 1525–1541 (2014).
  • Sodir NM , EvanGI. Finding cancer's weakest link. Oncotarget2 (12), 1307–1313 (2011).
  • Mund T , LewisMJ, MaslenS, PelhamHR. Peptide and small molecule inhibitors of HECT-type ubiquitin ligases. Proc. Natl Acad. Sci. USA111 (47), 16736–16741 (2014).
  • Heinis C , RutherfordT, FreundS, WinterG. Phage-encoded combinatorial chemical libraries based on bicyclic peptides. Nat. Chem. Biol.5 (7), 502–507 (2009).
  • Han Z , LuJ, LiuYet al. Small-molecule probes targeting the viral PPxY-Host Nedd4 interface block egress of a broad range of RNA viruses. J. Virol.88 (13), 7294–7306 (2014).
  • Dompe N , RiversCS, LiLet al. A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis. Proc. Natl Acad. Sci. USA108 (43), E943–E951 (2011).
  • Bradley A , ZhengH, ZiebarthAet al. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis35 (5), 1100–1109 (2014).
  • Chen D , YoonJB, GuW. Reactivating the ARF-p53 axis in AML cells by targeting ULF. Cell Cycle9 (15), 2946–2951 (2010).
  • Chio IIC , SasakiM, GhazarianDet al. TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation. Nat. Cell Biol.14 (6), 625–633 (2012).
  • Kathman SG , SpanI, SmithATet al. A small molecule that switches a ubiquitin ligase from a processive to a distributive enzymatic mechanism. J. Am. Chem. Soc. doi:10.1021/jacs.5b06839 (2015) ( Epub ahead of print).
  • Opitz R , MullerM, ReuterCet al. A modular toolkit to inhibit proline-rich motif-mediated protein-protein interactions. Proc. Natl Acad. Sci. USA112 (16), 5011–5016 (2015).
  • Rotin D , KumarS. Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol.10 (6), 398–409 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.